Finalist
Arc Bio Communications, an IQVIA Business
Summary of work
At Arc Bio, we’re passionate about delivering global communications strategies that add value and bring our clients’ innovations to life. Our unique approach blends the strategic rigour of management consultancy, the scientific expertise of medical education, and the creativity and reach of communications.
2024 was a transformative year that marked a new chapter for Arc Bio. Despite a challenging trading environment, we continued to achieve double-digit growth, scaling up our impact by opening up a US office and growing our biotech offer. It was also the year we became IQVIA’s strategic communications arm worldwide, strengthening both businesses and reinforcing our position.
Throughout this evolution, our culture remained our foundation – stronger than ever and driven by values that guide everything we do. We sharpened our focus, evolved our ways of working, and embraced new opportunities with the same energy and ambition that define us. As we step into the future, we do so with a stronger team, a broader reach, and an unwavering commitment to shaping the conversations that move healthcare forward.
Judges’ comments
Arc Bio’s presentation was strong and showed the strength of their business. The growth was impressive and they impressed the judges with how they have kept their brand and company personality following the merger.
